Accurate and Rapid Diagnosis of COVID-19 Pneumonia with Batch Effect Removal of Chest CT-Scans and Interpretable Artificial Intelligence

Rassa Ghavami, Mehrab Hamidi, Saeed Masoudian, Amir Mohseni, Hamzeh Lotfalinezhad, Mohammad Ali Kazemi, Behnaz Moradi, Mahyar Ghafoori, Omid Motamedi, Omid Pournik, Kiara Rezaei-Kalantari, Amirreza Manteghinezhad, Shaghayegh Haghjooy, Fateme Abdoli Nezhad, Ahmad Enhesari, Mohammad Saeed Kheyrkhah, Razieh Eghtesadi, Javid Azadbakht, Akbar Aliasgharzadeh, Mohammad Reza Sharif, Ali Khaleghi, Abbas Foroutan, Hossein Ghanaati, Hamed Dashti, Hamid R. Rabiee

Since late 2019, COVID-19 has been spreading over the world and caused the death of many people. The high transmission rate of the virus demands the rapid identification of infected patients to reduce the spread of the disease. The current gold-standard test, Reverse-Transcription Polymerase Chain Reaction (RT-PCR), suffers from a high rate of false negatives. Diagnosis from CT-scan images as an alternative with higher accuracy and sensitivity has the challenge of distinguishing COVID-19 from other lung diseases which demand expert radiologists. In peak times, artificial intelligence (AI) based diagnostic systems can help radiologists to accelerate the process of diagnosis, increase the accuracy, and understand the severity of the disease. We designed an interpretable deep neural network to distinguish healthy people, patients with COVID-19, and patients with other lung diseases from chest CT-scan images. Our model also detects the infected areas of the lung and is able to calculate the percentage of the infected volume. We preprocessed the images to eliminate the batch effect related to CT-scan devices and medical centers and then adopted a weakly supervised method to train the model without having any label for infected parts and any tags for the slices of the CT-scan images that had signs of disease. We trained and evaluated the model on a large dataset of 3359 CT-scan images from 6 medical centers. The model reached a sensitivity of 97.75% and a specificity of 87% in separating healthy people from the diseased and a sensitivity of 98.15% and a specificity of 81.03% in distinguishing COVID-19 from other diseases. The model also reached similar metrics in 1435 samples from 6 unseen medical centers that prove its generalizability. The performance of the model on a large diverse dataset, its generalizability, and interpretability makes it suitable to be used as a diagnostic system.

Knowledge Graph

arrow_drop_up

Comments

Sign up or login to leave a comment